RGC (Regencell) Return on Sales by Gross Profit

Official company branding of Regencell Bioscience Ltd (RGC)

Regencell Bioscience (RGC) minimal environmental footprint may seem like a formality, yet the quarterly gross margin on the GURU.Markets daily chart shows otherwise, where the 0.00 level reflects the current magnitude of efficiency. This is supported by the implementation of ethical raw material sourcing and transparent management. The fundamental resilience of the business is ensured by strict neuropharmaceutical regulation and robust patent protection of unique extracts.

Gross Profitability: Regencell Bioscience Holdings Limited (RGC) for 07/04/2022 - 11/19/2026

Financial and market metric breakdowns for regencellbioscience.com (RGC)

Fundamental valuation:RGC Regencell Bioscience Ltd
Core merchandise of Regencell Bioscience

Regencell Bioscience plans to monetize its developments in natural medicine through the sale of specialized formulas for ADHD and autism therapy. An analysis of gross margin history allows for an assessment of production efficiency by subtracting direct costs from revenue, which strips distortions from the business economics and confirms the fundamental stability of the stock's market value.

Main competitors

Return on Gross Profit Biogen Corp|Return on Gross Profit NBIX|AXSM: Gross Profit Rate|Gross Profitability acadia-pharm.com (ACAD)|Gross Margin Xenon Pharmaceuticals (XENE)|Gross Profitability Viking Therapeutics VKTX|Gross Profit Rate SUPN|CPRX - Gross Profitability|Gross Profit Margin Denali Therapeutics|HRMY: Gross Margin|Biohaven - Gross Profit Rate|Return on Gross Profit AMLX|Trevi Therapeutics, Inc. (TRVI) - Return on Sales by Gross Profit|Return on Gross Profit PRAX (Praxis Medicines)|Anavex Corp - Gross Return on Sales|Gross Profitability CeriBell CBLL|Return on Sales by Gross Profit Prothena Biosciences (PRTA)|ALEC: Return on Gross Profit|ANNX - Gross Margin|Omeros Corp. (OMER) - Gross Profitability|Gross Profit Margin Neurogene Inc. (NGNE)|Return on Gross Profit ACIU|Gross Profitability VYGR|Gross Profitability Neumora (NMRA)|SCLX - Gross Profit Margin|Gross Margin TVGN (Tevogen Bio Holdings Inc.)|Gross Profit Rate ACOG|Cognition Therapeutics Inc. - Gross Margin|IKT - Gross Margin|SAVA: Gross Margin|Assertio Holdings, Inc. - Gross Profit Rate|COYA (Coya) - Gross Margin|Gross Return on Sales VTGN (Vistagen Therapeutics)|Gross Profitability Ovid Rx (OVID)|Acumen Pharmaceuticals - Gross Return on Sales|Gross Profitability CervoMed, Inc. CRVO|Gross Margin Alterity Therapeutics ATHE|CLNN: Return on Gross Profit|PEPG (pepgen.com) - Gross Return on Sales|Jupiter Neurosciences Inc (JUNS) - Gross Profitability|Relmada Therapeutics - Gross Profit Rate|ANVS (Annovis Bio Inc) - Gross Margin|GRCE: Gross Profit Rate|Gross Profitability Firefly Neuroscience Inc (AIFF)|KLTO (ANEW Medical) - Gross Profit Rate|Gross Profitability neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Gross Profit Margin|MTVA: Return on Gross Profit|NeurAxis, Inc (NRXS) - Return on Gross Profit|HSDT: Gross Margin|PASG - Return on Sales by Gross Profit|Gross Profitability Neuphoria Therapeutics, Inc.|Gross Profitability NERV|Gross Margin ATHA|ADXN (Addex Therapeutics Ltd) - Gross Profit Rate|Gross Profitability alzamend.com ALZN|Return on Sales by Gross Profit Cyclerion Therapeutics (CYCN)|Protagenic - Gross Margin|Gross Profit Rate KTTA (Pasithea Therapeutics Corp)|CRGT: Gross Margin|Avenue Therapeutics Inc. (ATXI) - Gross Margin|BCLI (BrainStorm Cell Therapeutics Inc.) - Gross Margin|Gross Margin Cara Therapeutics Inc|Gross Profitability Chromocell Therapeutics (CHRO)|Gross Profit Ratio ELYM|Gross Profitability Intra-Cellular ITCI|LBPH: Gross Return on Sales|MRNS - Gross Profitability|NKGen Biotech, Inc. (NKGN) - Return on Gross Profit|neurobopharma.com (NRBO) - Gross Profitability|SAGE: Gross Profit Ratio|Gross Profitability Synaptogenix, Inc.|Gross Profitability TRVN|Gross Margin VIGL|Gross Margin anewmeds.com (WENA)|Gross Margin CERE (cerevel.com)